GTCbio's CNS World Summit 2014
With just over a month away until GTCbio presents its CNS Diseases World Summit 2014, attendees and interested parties have begun clamoring for the big day when they'll get to attend what has become one of the company's biggest events. The event, which will bring together academics and industry experts to the City by the Bay will take place from September 18-19 in San Francisco and has become known throughout the industry as an established meeting place for experts to discuss partnership, research, funding and drug development.
Discussing topics including Alzheimer’s, Parkinson’s, autism and Amyotrophic Lateral Sclerosis (ALS), the CNS conference will cover important industry questions such as:
What are opportunities for working with patient advocacy groups?
How do small companies and start-ups fit in the space, especially give pharmaceutical companies decreased involvement?
What is the role of private/public partnerships?
What are the research opportunities and risks associated with rare CNS disorders?
With dozens of distinguished biotechnology speakers presenting at the scientific event, the CNS Diseases World Summit 2014 will feature such presenters as:
Steven Finkbeiner
Director, Taube-Koret Center for Neurodegenerative Disease Research
University of California, San Francisco
Daniel Grau
President
Heptares Therapeutics
Darryle Schoepp
Vice President and Therapeutic Area Head, Neuroscience, Early Development and Discovery Sciences
Merck
Rajesh Ranganathan
Director, Translational Research
National Institutes of Health
For more information on how you can attend this amazing event, please visit GTCbio or give us a call at (626) 256-6405 today!